Thai hospital tycoon sticks to guns on vaccine claims


Dr Boon Vanasin insists a deal was in the works through a government agency. - Reuters

BANGKOK (Reuters): Thailand’s Thonburi Healthcare Group Pcl (THG) doubled down on its outspoken chairman's claim to be buying Pfizer-BioNTech vaccines on Friday (July 16), helping its share price rise despite denials by both drugmakers.

Dr Boon Vanasin's claim that his group, a more than US$800 million private medicine empire, was close to signing a deal for 20 million Pfizer-BioNTech coronavirus vaccines to import to Thailand was swiftly denied on Thursday by both companies, one day after a government agency filed a defamation suit against Boon, 82.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Thailand , Dr Boon Vanasin , Thonburi , Health , Group , Pfizer , vaccine

   

Next In Aseanplus News

Asean News Headlines at 10pm on Thursday (Nov 14, 2024)
Cricket-ICC in talks with boards over non-payment of T20 World Cup dues to players
Talks spotlight cyberbullying in Brunei schools
Vietnam looks to restart nuclear power projects
Future Lao legal practitioners welcome Japan International Cooperation Agency experts’ lecture
Free condoms, HIV testing for public during Cambodian Water Festival
Late Mandopop diva Coco Lee’s grave falls into disrepair after just one year, leaving fans heartbroken
Malaysia, Singapore sign MOU to combat cross-border crime
Quiboloy undergoes more medical tests at Philippine Children’s hospital, says police
Three-day series of events to mark two years of Madani Govt

Others Also Read